Torthaí cuardaigh - Masafuchi Ryo
- 1 - 2 toradh as 2 á dtaispeáint
-
1
Neurological safety of fingolimod: An updated review de réir Fumihito Yoshii, Yusuke Moriya, Tomohide Ohnuki, Masafuchi Ryo, Wakoh Takahashi
Foilsithe / Cruthaithe 2017Revisão -
2
I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway de réir Etsuro Ohta, Tomoko Nihira, A Uchino, Yoichi Imaizumi, Yohei Okada, Wado Akamatsu, Kayoko Takahashi, Hideki Hayakawa, Makiko Nagai, Manabu Ohyama, Masafuchi Ryo, Mieko Ogino, Shigeo Murayama, Akihiko Takashima, Kazutoshi Nishiyama, Yoshikuni Mizuno, Hideki Mochizuki, Fumiya Obata, Hideyuki Okano
Foilsithe / Cruthaithe 2015Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Disease
Internal medicine
Medicine
Adverse effect
Biology
Cancer research
Cell biology
Clinical trial
Embryonic stem cell
Fingolimod
GSK-3
GSK3B
Gene
Genetics
Glycogen synthase
Immunology
Induced pluripotent stem cell
Kinase
LRRK2
Leukoencephalopathy
Multiple sclerosis
Mutant
Mutation
Natalizumab
Neurodegeneration
Neurology
Neuromyelitis optica
Neuroscience
Parkinson's disease
Pediatrics